PTPRC and hepatocellular carcinoma: Further, CD45+ CECs from patients with HCC inhibit CD4+ T cell proliferation and differentiation and suppress CD8+ T cell proliferation and cytotoxicity by generating factors including ROS, IL-10, and TGF-β (165).